• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. INSYTE AUTOGUARD; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. INSYTE AUTOGUARD; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 381923
Medical Device Problem Codes Material Puncture/Hole (1504); Material Split, Cut or Torn (4008)
Health Effect - Clinical Code Pain (1994)
Date of Event 11/12/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
B3.The date received by manufacturer has been used for this field.H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
 
Event or Problem Description
Adverse effects (note precisely the terms used by the notifier): several users reported that when inserting the seal into the patient's vein, the needle pierced the catheter.17-nov-2025 i have no further information beyond what i have already provided.27-nov-2025 - response received 1.Did the user attempt to retract the needle? if so, did the needle retract? no 2.Was there any impact on the patient or healthcare professional? patient pain at the puncture site 3.How was the procedure completed? the healthcare professional had to reinsert the needle 4.As you indicated, ¿several users have reported¿ this problem.Could you confirm the number of patients affected and provide the respective dates of the events? unable to provide dates, approximately 10.
 
Event or Problem Description
No new information.
 
Additional Manufacturer Narrative
The complaint that the needle pierced the catheter could not be confirmed from the representative 22g insyte autoguard devices that were received in sealed unit packages.A visual examination and functional test revealed no damage or defects associated with the reported event.The affected units were not provided for investigation.Although the representative samples and manufacturing records do not support the complainant¿s description of the reported event, the complaint has been documented and will continue to be monitored as part of ongoing efforts to identify potential manufacturing related issues.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSYTE AUTOGUARD
Common Device Name
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key23722900
Report Number1710034-2025-01897
Device Sequence Number10209547
Product Code FOZ
UDI-Device Identifier00382903819232
UDI-Public(01)00382903819232
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K201075
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Risk Manager
Type of Report Initial,Followup
Report Date (Section B) 01/13/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number381923
Device Lot Number5051381
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/12/2025
Supplement Date Received by Manufacturer01/13/2026
Initial Report FDA Received Date12/04/2025
Supplement Report FDA Received Date01/13/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/25/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-